News on Allergy_And_Immunology from BioPortfolio.com http://www.BioPortfolio.com Consolidated Allergy_And_Immunology news from BioPortfolio.com Wed, 10 Feb 2010 03:41:57 GMT en Allergic rhinitis a significant risk factor for asthma developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038757&HITNO=0&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038757&THISHREF=http://c.moreover.com/click/here.pl%3fz2537749687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038757&HITNO=0&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038757&THISHREF=http://c.moreover.com/click/here.pl%3fz2537749687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: New Item on Pediatric Menu: Food Allergyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039193&HITNO=1&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039193&THISHREF=http://c.moreover.com/click/here.pl%3fz2537971431%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039193&HITNO=1&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039193&THISHREF=http://c.moreover.com/click/here.pl%3fz2537971431%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of the American Medical Association: Allergen exposure increases Th2-cytokines and FOXP3 expression in asthmatic lungshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038756&HITNO=2&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038756&THISHREF=http://c.moreover.com/click/here.pl%3fz2537749560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038756&HITNO=2&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038756&THISHREF=http://c.moreover.com/click/here.pl%3fz2537749560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Early exposure to solid foods and the development of eczema in children up to 4 years of agehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034165&HITNO=3&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034165&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034165&HITNO=3&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034165&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Herbals Not the Answer for Asthma, Study Showshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036145&HITNO=4&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036145&THISHREF=http://c.moreover.com/click/here.pl%3fz2536508654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036145&HITNO=4&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036145&THISHREF=http://c.moreover.com/click/here.pl%3fz2536508654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038542&HITNO=5&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038542&THISHREF=http://c.moreover.com/click/here.pl%3fz2537650708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038542&HITNO=5&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038542&THISHREF=http://c.moreover.com/click/here.pl%3fz2537650708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037140&HITNO=6&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037140&THISHREF=http://c.moreover.com/click/here.pl%3fz2536919873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037140&HITNO=6&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037140&THISHREF=http://c.moreover.com/click/here.pl%3fz2536919873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037009&HITNO=7&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037009&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037009&HITNO=7&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037009&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036991&HITNO=8&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036991&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036991&HITNO=8&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036991&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036988&HITNO=9&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536856680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036988&HITNO=9&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536856680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036061&HITNO=10&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036061&THISHREF=http://c.moreover.com/click/here.pl%3fz2536484788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036061&HITNO=10&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036061&THISHREF=http://c.moreover.com/click/here.pl%3fz2536484788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035211&HITNO=11&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035211&THISHREF=http://c.moreover.com/click/here.pl%3fz2536158644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035211&HITNO=11&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035211&THISHREF=http://c.moreover.com/click/here.pl%3fz2536158644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: GeoVax Labs provides update on vaccine trials progresshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034625&HITNO=12&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034625&THISHREF=http://c.moreover.com/click/here.pl%3fz2535894643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034625&HITNO=12&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034625&THISHREF=http://c.moreover.com/click/here.pl%3fz2535894643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Paxil blocks effect of breast cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034253&HITNO=13&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034253&THISHREF=http://c.moreover.com/click/here.pl%3fz2535689856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034253&HITNO=13&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034253&THISHREF=http://c.moreover.com/click/here.pl%3fz2535689856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comToronto Star Online: GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032550&HITNO=14&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032550&THISHREF=http://c.moreover.com/click/here.pl%3fz2534701587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032550&HITNO=14&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy_And_Immunology&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032550&THISHREF=http://c.moreover.com/click/here.pl%3fz2534701587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: